GO:0002821 positive regulation of adaptive immune response: Immune Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002821 (positive regulation of adaptive immune response) describes any process that activates or increases the frequency, rate, or extent of an adaptive immune response.
• This process is central to protective immunity, vaccine efficacy, and immunotherapy, including checkpoint blockade in cancer.
• Key cell types include T cells, B cells, and antigen-presenting cells, whose interactions are modulated by cytokines such as TSLP and IgE.
• Metabolic reprogramming of germinal center B cells is a critical node in regulating adaptive immunity.
• Dysregulation of this process contributes to autoimmunity, chronic infection, and tumor immune evasion.
• CRISPR-based models (knockout, knock-in, overexpression) enable causal dissection of genes that positively regulate adaptive immunity.
Description
The adaptive immune response is a hallmark of vertebrate immunity, characterized by antigen specificity and immunological memory. GO:0002821, positive regulation of adaptive immune response, encompasses any process that activates or increases the frequency, rate, or extent of this response. This term is essential for understanding how the immune system is amplified during infection, vaccination, and cancer immunotherapy. Research into this process has revealed that positive regulation can occur at multiple levels, including antigen presentation, co-stimulation, cytokine signaling, and metabolic reprogramming. For example, PD-1 blockade induces responses by inhibiting adaptive immune resistance, effectively enhancing positive regulation of adaptive immunity in the tumor microenvironment. Similarly, in chronic hepatitis B, functional cure is associated with restored adaptive immune responses, highlighting the clinical relevance of this GO term. As a biological process, GO:0002821 is not restricted to a single cell type or pathway; it integrates signals from innate immune cells, such as macrophages and dendritic cells, and adaptive lymphocytes. Understanding the molecular players that positively regulate adaptive immunity is crucial for developing therapies against cancer, infectious diseases, and autoimmune disorders.
positive regulation of adaptive immune response At A Glance
| GO ID | GO:0002821 |
|---|---|
| GO term | positive regulation of adaptive immune response |
| Ontology | biological_process |
| Synonym | activation of adaptive immune response; stimulation of adaptive immune response; up regulation of adaptive immune response; up-regulation of adaptive immune response; upregulation of adaptive immune response |
| Major function | Activates or increases the frequency, rate, or extent of an adaptive immune response |
| Related cell types | T cells, B cells, antigen-presenting cells, macrophages |
| Key signaling molecules | Cytokines (e.g., TSLP, IgE), checkpoint receptors (e.g., PD-1), metabolic regulators (e.g., mTOR) |
| Disease relevance | Cancer, chronic infections, autoimmunity, allergy |
What Is GO:0002821?
In simple terms, GO:0002821 describes the set of biological events that boost or turn up the adaptive immune response. According to QuickGO, it is defined as any process that activates or increases the frequency, rate, or extent of an adaptive immune response. This includes signals that enhance T cell activation, B cell differentiation, antibody production, and memory formation. It is a biological process term, and its synonyms include activation of adaptive immune response, stimulation of adaptive immune response, up regulation of adaptive immune response, up-regulation of adaptive immune response, and upregulation of adaptive immune response.
Why Is positive regulation of adaptive immune response Important in Cell Biology?
Positive regulation of adaptive immune response is a cornerstone of protective immunity and immunotherapy. It determines the strength and durability of responses to vaccines and infections, and its manipulation can overcome immune evasion in cancer. For instance, PD-1 blockade relies on enhancing adaptive immune responses to eliminate tumors. In chronic hepatitis B, achieving functional cure is linked to restoring positive regulation of adaptive immunity. Moreover, dysregulated positive regulation can lead to autoimmunity or allergy, as seen with IgE and TSLP in asthma. Thus, understanding this process is vital for designing interventions that either boost immunity against pathogens and tumors or dampen it in autoimmune diseases.
• Vaccine development: positive regulation determines the magnitude and memory of vaccine-induced responses.
• Cancer immunotherapy: checkpoint inhibitors like PD-1 blockade enhance adaptive immunity to tumors.
• Chronic infections: restoration of adaptive immunity is key to functional cure in hepatitis B.
• Allergy and asthma: TSLP and IgE modulate adaptive immune responses, offering therapeutic targets.
• Autoimmunity: excessive positive regulation can drive autoimmune pathology.
• Metabolic regulation: germinal center responses are tuned by immune metabolism.
• Macrophage reprogramming: targeting USP7 modulates anti-tumor immunity.
• Liver immunity: priming and maintenance of adaptive immunity in the liver is critical for local and systemic protection.
• Inflammation: innate and adaptive lymphocytes regulate inflammation, impacting disease outcomes.
• Therapeutic targeting: understanding positive regulation enables drug development for immune-related disorders.
What Happens During positive regulation of adaptive immune response?
Antigen Presentation and Co-stimulation
In simple terms: This is the step where immune cells show pieces of pathogens to T cells and give them a green light to attack.
Positive regulation begins with efficient antigen presentation by dendritic cells, macrophages, and B cells. Co-stimulatory signals, such as CD28-B7 interactions, are essential to activate T cells. In the liver, priming and maintenance of adaptive immunity involve specialized antigen-presenting cells that can either promote tolerance or immunity. The strength of antigen presentation directly influences the frequency and extent of adaptive immune activation.
Cytokine and Checkpoint Modulation
In simple terms: Cytokines are chemical messengers that can either boost or brake the immune response, and checkpoints are like brakes that can be released.
Cytokines such as thymic stromal lymphopoietin (TSLP) and IgE can positively regulate adaptive immune responses, particularly in allergic inflammation. Conversely, checkpoint receptors like PD-1 deliver inhibitory signals; blocking PD-1 with antibodies enhances adaptive immunity against tumors. Thus, the balance of stimulatory and inhibitory cytokines and checkpoints determines the net positive regulation.
Metabolic Reprogramming of Lymphocytes
In simple terms: Immune cells need energy to work, and how they use nutrients can turn their activity up or down.
Metabolic pathways, including mTOR signaling and glycolysis, regulate the germinal center response and antibody production. Positive regulation of adaptive immunity requires adequate metabolic support for rapid proliferation and effector functions of B and T cells. Targeting metabolic enzymes can therefore modulate the intensity of adaptive immune responses.
Macrophage and Innate Immune Crosstalk
In simple terms: Innate immune cells like macrophages can send signals that amplify the adaptive immune response.
Tumor-associated macrophages can be reprogrammed to support anti-tumor adaptive immunity. For example, targeting USP7 modulates anti-tumor immune response by reprogramming macrophages in lung cancer. This crosstalk highlights how innate cells positively regulate adaptive immunity.
Germinal Center and Memory Formation
In simple terms: This is where B cells fine-tune their antibodies and become long-lived memory cells.
The germinal center reaction is a key component of positive regulation, leading to high-affinity antibodies and memory B cells. Positive regulation ensures the frequency and extent of germinal center responses are sufficient for durable immunity. Dysregulation can lead to autoantibody production or insufficient memory.
Key Genes Involved in GO:0002821 positive regulation of adaptive immune response
The following genes and proteins are central to positive regulation of adaptive immune response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDCD1 (PD-1) | Inhibitory checkpoint receptor on T cells | Blockade enhances adaptive immunity in cancer |
| CD274 (PD-L1) | Ligand for PD-1, mediates immune evasion | Target for checkpoint blockade |
| TSLP | Cytokine that activates dendritic cells | Promotes Th2 responses in asthma |
| IGHE (IgE) | Antibody involved in allergic responses | Regulates adaptive immunity in allergy |
| USP7 | Deubiquitinase that modulates macrophage polarization | Targeting reprograms TAMs to boost anti-tumor immunity |
| MTOR | Kinase that integrates metabolic signals | Regulates germinal center response |
| MYC | Transcription factor driving proliferation | Supports germinal center B cell expansion |
| BCL6 | Transcriptional repressor | Required for germinal center formation |
| PRDM1 (BLIMP1) | Transcriptional repressor | Regulates plasma cell differentiation |
| XBP1 | Transcription factor for plasma cell differentiation | Controls antibody secretion |
| CD40LG (CD40L) | Co-stimulatory molecule on T cells | Essential for B cell activation |
| CD28 | Co-stimulatory receptor on T cells | Provides second signal for T cell activation |
| CTLA4 | Inhibitory receptor on T cells | Checkpoint target in cancer |
| IL2 | Cytokine promoting T cell proliferation | Enhances adaptive immunity |
| IL4 | Cytokine driving Th2 differentiation | Regulates allergic responses |
| IL21 | Cytokine supporting B cell differentiation | Promotes germinal center reactions |
| IFNG | Cytokine activating macrophages | Enhances cell-mediated immunity |
How Is positive regulation of adaptive immune response Regulated?
Positive regulation of adaptive immune response is tightly controlled by multiple mechanisms. Checkpoint receptors such as PD-1 and CTLA-4 provide inhibitory signals that can be blocked to enhance immunity. Cytokines like TSLP and IgE can amplify allergic adaptive responses. Metabolic regulators, including mTOR, sense nutrient availability and modulate germinal center reactions. Additionally, deubiquitinases like USP7 influence macrophage polarization and subsequent T cell activation. The liver microenvironment also shapes adaptive immunity through priming and maintenance signals. These regulatory layers ensure that positive regulation is context-dependent and reversible.
positive regulation of adaptive immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDCD1 | Cancer immune evasion | PD-1 knockout mice or cell lines for checkpoint studies |
| TSLP | Asthma and allergy | TSLP transgenic or knockout mouse models |
| USP7 | Lung cancer | USP7 knockout or inhibitor-treated macrophage co-culture |
| MTOR | Germinal center dysregulation | mTOR conditional knockout in B cells |
| IGHE | Allergic diseases | IgE knockout or humanized mouse models |
Cancer Immunotherapy
In cancer, tumors often evade adaptive immunity by upregulating checkpoint ligands like PD-L1. PD-1 blockade inhibits adaptive immune resistance and restores positive regulation, leading to tumor regression in some patients. Targeting USP7 in lung cancer reprograms tumor-associated macrophages and enhances anti-tumor adaptive immunity. Thus, manipulating positive regulation is a cornerstone of cancer immunotherapy.
Chronic Viral Infections
Chronic hepatitis B is characterized by impaired adaptive immunity. Functional cure is associated with restoration of positive regulation of adaptive immune responses, including T cell and B cell functions. Understanding how to boost these responses is critical for developing curative therapies.
Allergy and Asthma
In allergic asthma, TSLP and IgE positively regulate adaptive immune responses, leading to Th2 inflammation and airway hyperresponsiveness. Targeting TSLP or IgE can dampen this excessive positive regulation and alleviate symptoms.
Autoimmune and Inflammatory Diseases
Dysregulated positive regulation can contribute to autoimmunity and chronic inflammation. Innate and adaptive lymphocytes regulate inflammation, and their overactivation can lead to tissue damage. Modulating positive regulation is a therapeutic strategy for autoimmune diseases.
From positive regulation of adaptive immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate T cell activation? | Knockout of gene X in primary T cells or Jurkat cells |
| Does a point mutation in gene Y affect adaptive immunity? | Point-mutation knock-in mice or cell lines |
| Can overexpression of gene Z enhance anti-tumor immunity? | Overexpression cell lines or transgenic mice |
| What is the role of gene W in germinal center formation? | Conditional knockout in B cells |
| Does a tagged version of protein V localize to immune synapses? | Tagged knock-in (e.g., GFP) |
| Can CRISPR library screening identify novel regulators? | Genome-wide knockout library in immune cells |
How to Study the positive regulation of adaptive immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Frequency and phenotype of immune cells | T cell activation, B cell differentiation |
| ELISA/Luminex | Cytokine concentrations | Th1/Th2 responses |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Metabolic regulation of germinal centers |
| CRISPR screen | Gene essentiality for immune activation | Discovery of novel regulators |
| RNA-seq | Transcriptional changes | Pathway analysis of activated lymphocytes |
| Western blot | Protein expression and phosphorylation | Checkpoint signaling |
| Immunohistochemistry | Tissue localization of immune cells | Tumor immune infiltration |
| Tetramer staining | Antigen-specific T cells | Vaccine and infection studies |
Flow Cytometry and Immunophenotyping
Flow cytometry is used to measure the frequency and activation status of T cells, B cells, and antigen-presenting cells. It can quantify positive regulation by assessing surface markers like CD69, CD25, and intracellular cytokines.
Cytokine Profiling
ELISA, Luminex, or intracellular cytokine staining measure cytokines such as IFN-gamma, IL-2, and IL-4, which reflect the extent of adaptive immune activation.
Metabolic Assays
Seahorse extracellular flux analysis and glucose uptake assays assess metabolic reprogramming in germinal center B cells and T cells, linking metabolism to positive regulation.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens in immune cells can identify genes that positively regulate adaptive immune responses, such as those affecting T cell proliferation or cytokine production.
How CRISPR Can Be Used to Study GO:0002821 positive regulation of adaptive immune response
Knockout
CRISPR knockout of candidate genes in immune cell lines or primary cells can determine whether the gene is required for positive regulation of adaptive immune responses. For example, knocking out PDCD1 in T cells enhances their activation, mimicking checkpoint blockade. Knockout of USP7 in macrophages alters their polarization and subsequent T cell activation.
Point Mutation
Point mutations can be introduced to model disease-associated variants or to dissect specific domains. For instance, mutating phosphorylation sites in signaling molecules can reveal their role in adaptive immunity. This approach is useful for studying gain-of-function or loss-of-function mutations in genes like MTOR.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows tracking of specific proteins during adaptive immune responses. Knock-in of human disease alleles into mouse models can recapitulate human immune dysregulation. This is valuable for studying gene dosage and localization.
Overexpression
Overexpression of a candidate gene can test whether it is sufficient to enhance adaptive immunity. For example, overexpressing TSLP in mice promotes allergic inflammation. Overexpression of constitutively active mTOR boosts germinal center responses.
How EDITGENE Supports positive regulation of adaptive immune response Research
Researchers studying positive regulation of adaptive immune response-related genes often need to determine whether a candidate gene is causally involved in boosting immunity. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of adaptive immune response research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IL6ST Knockout HEK293 Cell Line | EDJ-KQ134 | Human | 3572 | Details Get a Quote |
| SIRT1 Knockout HEK293 Cell Line | EDJ-KQ1128 | Human | 23411 | Details Get a Quote |
| SKAP1 Knockout HEK293 Cell Line | EDJ-KQ1310 | Human | 8631 | Details Get a Quote |
| FADD Knockout HEK293 Cell Line | EDJ-KQ1473 | Human | 8772 | Details Get a Quote |
| EIF2AK4 Knockout HEK293 Cell Line | EDJ-KQ1936 | Human | 440275 | Details Get a Quote |
| PYCARD Knockout HEK293 Cell Line | EDJ-KQ2182 | Human | 29108 | Details Get a Quote |
| SASH3 Knockout HEK293 Cell Line | EDJ-KQ11417 | Human | 54440 | Details Get a Quote |
| SKAP1 Knockout HCT 116 Cell Line | EDJ-KQ18062 | Human | 8631 | Details Get a Quote |
| FADD Knockout A-549 Cell Line | EDJ-KQ21049 | Human | 8772 | Details Get a Quote |
| FADD Knockout HCT 116 Cell Line | EDJ-KQ21050 | Human | 8772 | Details Get a Quote |
| FADD Knockout HeLa Cell Line | EDJ-KQ21051 | Human | 8772 | Details Get a Quote |
| IL6ST Knockout A-549 Cell Line | EDJ-KQ18815 | Human | 3572 | Details Get a Quote |
| IL6ST Knockout HCT 116 Cell Line | EDJ-KQ18816 | Human | 3572 | Details Get a Quote |
| IL6ST Knockout HeLa Cell Line | EDJ-KQ18817 | Human | 3572 | Details Get a Quote |
| SIRT1 Knockout A-549 Cell Line | EDJ-KQ20328 | Human | 23411 | Details Get a Quote |
Displaying Records 1 To 15 Of 30 Records
Frequently Asked Questions About positive regulation of adaptive immune response
What is GO:0002821?
GO:0002821 is the Gene Ontology term for positive regulation of adaptive immune response, defined as any process that activates or increases the frequency, rate, or extent of an adaptive immune response.
What genes are involved in positive regulation of adaptive immune response?
Key genes include PDCD1, CD274, TSLP, IGHE, USP7, MTOR, and many cytokines and transcription factors.
How is positive regulation of adaptive immune response studied?
It is studied using flow cytometry, cytokine profiling, metabolic assays, and CRISPR screens in immune cells.
Why is positive regulation of adaptive immune response important in cancer?
Enhancing this process through checkpoint blockade can overcome tumor immune evasion and lead to tumor regression.
What role does TSLP play in adaptive immunity?
TSLP activates dendritic cells and promotes Th2 adaptive immune responses, contributing to asthma pathogenesis.
How does IgE regulate adaptive immune responses?
IgE can modulate adaptive immunity by affecting mast cells and dendritic cells, particularly in allergic inflammation.
Can CRISPR be used to study positive regulation of adaptive immune response?
Yes, CRISPR knockout, knock-in, and overexpression models allow causal dissection of genes in this process.
What diseases are associated with dysregulated positive regulation of adaptive immune response?
Cancer, chronic hepatitis B, asthma, allergy, and autoimmune diseases.
What is the role of metabolism in positive regulation of adaptive immune response?
Metabolic reprogramming, such as mTOR signaling, supports germinal center reactions and lymphocyte activation.
How does the liver contribute to adaptive immunity?
The liver primes and maintains adaptive immunity through specialized antigen-presenting cells and local signals.
Conclusion
GO:0002821, positive regulation of adaptive immune response, is a fundamental biological process that governs the strength and duration of immunity. Its manipulation holds promise for cancer immunotherapy, vaccines, and treatments for chronic infections and allergies. Continued research using CRISPR and other advanced tools will uncover new therapeutic targets and mechanisms. EDITGENE is committed to supporting this research with tailored CRISPR services.
References
- 1. Kawashima K et al.. 2024. Priming and Maintenance of Adaptive Immunity in the Liver.. Annu Rev Immunol 42(1):375-399 PMID: 38360545
- 2. Tumeh PC et al.. 2014. PD-1 blockade induces responses by inhibiting adaptive immune resistance.. Nature 515(7528):568-71 PMID: 25428505
- 3. Zheng JR et al.. 2022. Hepatitis B functional cure and immune response.. Front Immunol 13:1075916 PMID: 36466821
- 4. Gauvreau GM et al.. 2020. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma.. Expert Opin Ther Targets 24(8):777-792 PMID: 32567399
- 5. Dai X et al.. 2020. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.. Theranostics 10(20):9332-9347 PMID: 32802195
- 6. Choi SC et al.. 2020. Immune metabolism regulation of the germinal center response.. Exp Mol Med 52(3):348-355 PMID: 32132626
- 7. Engeroff P et al.. 2025. IgE in the Regulation of Adaptive Immune Responses.. Immunol Rev 331(1):e70030 PMID: 40322927
- 8. Cronkite DA et al.. 2018. The Regulation of Inflammation by Innate and Adaptive Lymphocytes.. J Immunol Res 2018:1467538 PMID: 29992170
